← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 30, 2019Last known activity
May 25, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 2 trials)
Phase 3 (2 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (2)
- NCT05291325CollaboratorN/AMay 25, 2022
- NCT03984760Overall official - principal investigatorPhase 3Jun 30, 2019
Details
- Last known activity
- May 25, 2022